[go: up one dir, main page]

SG90259A1 - Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections - Google Patents

Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections

Info

Publication number
SG90259A1
SG90259A1 SG200104942A SG200104942A SG90259A1 SG 90259 A1 SG90259 A1 SG 90259A1 SG 200104942 A SG200104942 A SG 200104942A SG 200104942 A SG200104942 A SG 200104942A SG 90259 A1 SG90259 A1 SG 90259A1
Authority
SG
Singapore
Prior art keywords
plant
prevention
derived
effective
treatment
Prior art date
Application number
SG200104942A
Other languages
English (en)
Inventor
Vuorela Heikki
Vuorela Pia
Hiltunen Raimo
Leinonen Maija
Saikku Pekka
Original Assignee
Control Ox Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20001832A external-priority patent/FI113942B/fi
Application filed by Control Ox Oy filed Critical Control Ox Oy
Publication of SG90259A1 publication Critical patent/SG90259A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG200104942A 2000-08-17 2001-08-14 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections SG90259A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22573500P 2000-08-17 2000-08-17
FI20001832A FI113942B (fi) 2000-08-18 2000-08-18 Kasviperäisten fenolisten yhdisteiden käyttö valmistettaessa klamydiainfektion hoidossa ja ennaltaehkäisyssä käyttökelpoista farmaseuttista valmistetta, terveyteen myönteisesti vaikuttavaa ravintoainekoostumusta tai koostumusta lisättäväksi tällaisiin elintarvikkeisiin

Publications (1)

Publication Number Publication Date
SG90259A1 true SG90259A1 (en) 2002-07-23

Family

ID=26161043

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200104942A SG90259A1 (en) 2000-08-17 2001-08-14 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections

Country Status (21)

Country Link
EP (1) EP1309333B1 (fr)
JP (1) JP2004506656A (fr)
KR (1) KR100851357B1 (fr)
CN (1) CN100500141C (fr)
AR (1) AR034141A1 (fr)
AT (1) ATE441424T1 (fr)
AU (2) AU8220101A (fr)
BR (1) BR0113463A (fr)
CA (1) CA2419716A1 (fr)
CZ (1) CZ2003449A3 (fr)
DE (1) DE60139783D1 (fr)
EE (1) EE200300064A (fr)
ES (1) ES2330306T3 (fr)
HU (1) HUP0300732A3 (fr)
MX (1) MXPA03001435A (fr)
NO (1) NO20030728L (fr)
NZ (1) NZ524128A (fr)
PT (1) PT1309333E (fr)
SG (1) SG90259A1 (fr)
TW (1) TWI282275B (fr)
WO (1) WO2002014464A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4571829B2 (ja) * 2003-07-15 2010-10-27 林原 健 抗クラミジア組成物
US8455541B2 (en) 2005-05-30 2013-06-04 Korea Research Institute Of Bioscience And Biotechnology Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
US8168235B2 (en) 2005-05-30 2012-05-01 Korea Research Institute Of Bioscience And Biotechnology Pharmaceutical composition comprising an extract of Pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
FR2890311B1 (fr) * 2005-09-07 2009-10-30 Oreal Utilisation cosmetique d'un extrait vegetal du genre rosa comme agent empechant ou reduisant l'adhesion des microorganismes sur la surface de la peau et/ou des muqueuses
WO2009003832A2 (fr) * 2007-07-05 2009-01-08 Unilever N.V. Composition comprenant des polyphénols
WO2009003838A2 (fr) * 2007-07-05 2009-01-08 Unilever N.V. Composition comprenant des polyphénols
DK2585088T3 (da) 2010-06-25 2014-08-25 Horphag Res Ip Pre Ltd Sammensætning til forbedring af seksuel sundhed
CN102935131B (zh) * 2011-08-15 2015-01-07 天津药物研究院 枳实总黄酮提取物在制备用于治疗哮喘药物中的应用
KR101419706B1 (ko) * 2012-12-28 2014-07-15 한국식품연구원 생체내에서의 항염증 효능이 증가된 염증치료용 루테올린 혼합 조성물을 제조하는 방법 및 항염증이 증가된 염증치료용 루테올린 혼합 조성물
KR102105532B1 (ko) * 2013-10-17 2020-04-29 (주)아모레퍼시픽 만능 줄기세포의 유도 방법 및 상기 방법에 의해 제조된 만능줄기세포
EP3236978B1 (fr) * 2014-12-23 2023-06-14 Mootral SA Composition antimicrobienne
US10039727B2 (en) 2015-04-21 2018-08-07 Commissariat A L'energie Atomique Et Aux Energies Alternatives Adamantane or pinene derivatives for use in the treatment of chlamydiales infections
IT201700089680A1 (it) * 2017-08-03 2019-02-03 Giuliani Spa Composizione sinergica come promoter di autofagia/a synergistic composition as a promoter of autophagy
KR102313068B1 (ko) 2018-08-01 2021-10-14 건국대학교 산학협력단 비아칸젤리신을 포함하는 폐 또는 뇌의 생체분포도 증진을 위한 약제학적 제형
KR102166099B1 (ko) 2018-08-01 2020-10-15 건국대학교 산학협력단 비아칸젤리신을 포함하는 폐 또는 뇌의 생체분포도 증진을 위한 약제학적 제형
CN111675220B (zh) * 2020-05-08 2023-06-27 江西江氨科技有限公司 碳酸酯生产尾气中含co2提取精制系统
CN113024575B (zh) * 2021-03-23 2022-04-22 上海市奉贤区中心医院 一种黄烷-3-醇并苯丙素杂合物、其制备方法及其应用
CN116078128B (zh) * 2022-11-30 2024-12-06 北京华能长江环保科技研究院有限公司 阴燃烟气处理方法和系统以及固废处理系统
CN119792331B (zh) * 2025-03-17 2025-07-04 天津医科大学总医院 一种小分子化合物k3g在治疗衣原体感染中的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026197A1 (fr) * 1994-03-25 1995-10-05 Jlb, Inc. Composition inhibant l'adhesion
WO1999012541A1 (fr) * 1997-09-09 1999-03-18 Rutgers, The State University Of New Jersey Extrait de proanthocyanidine d'origine vegetale empechant efficacement une adherence de bacteries a fimbriae de type p a des surfaces
EP1005862A1 (fr) * 1998-04-21 2000-06-07 Mitsui Norin Co., Ltd. Agents anti-chlamidia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3206725A1 (de) * 1981-05-13 1982-12-02 Merck Patent Gmbh, 6100 Darmstadt Schwer loesliche salze von aminoglykosidantibiotika
ATE87204T1 (de) * 1987-12-10 1993-04-15 Tsumura & Co Anti-retrovirales arzneimittel.
US4891221A (en) 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
EP0496230A1 (fr) * 1991-01-23 1992-07-29 ASTA Medica Aktiengesellschaft Préparation d'un extrait de camomille à qualité antimicrobienne
CN1106682A (zh) * 1994-02-05 1995-08-16 蔡惠明 一种用于治疗妇女阴道炎及常见性病预防的中药制剂
CN1151846A (zh) * 1995-12-15 1997-06-18 四川保宁制药厂 银杏保健饮料
ATE268178T1 (de) * 1997-07-11 2004-06-15 Toray Industries Stabile medizinische zusammenstellungen die 4,5- epoxymorphinanderivate enthalten
WO1999025699A1 (fr) * 1997-11-19 1999-05-27 Tets, Viktor Veniaminoich Sels d'acides 5,5'-arylidenebisbarbituriques et 5,5'-arylidenebis(2-thiobarbituriques) et acides 5,5'-arylidenebis(2-thiobarbituriques) ayant une action antibacterienne, anti-chlamydiose, antivirale et immuno-modulatrice
CN1226405A (zh) * 1998-12-17 1999-08-25 童忠良 银杏沙棘饮料

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995026197A1 (fr) * 1994-03-25 1995-10-05 Jlb, Inc. Composition inhibant l'adhesion
WO1999012541A1 (fr) * 1997-09-09 1999-03-18 Rutgers, The State University Of New Jersey Extrait de proanthocyanidine d'origine vegetale empechant efficacement une adherence de bacteries a fimbriae de type p a des surfaces
EP1005862A1 (fr) * 1998-04-21 2000-06-07 Mitsui Norin Co., Ltd. Agents anti-chlamidia

Also Published As

Publication number Publication date
ES2330306T3 (es) 2009-12-09
EE200300064A (et) 2004-12-15
CN1454093A (zh) 2003-11-05
JP2004506656A (ja) 2004-03-04
CN100500141C (zh) 2009-06-17
NO20030728L (no) 2003-04-14
WO2002014464B1 (fr) 2002-11-21
CA2419716A1 (fr) 2002-02-21
EP1309333A2 (fr) 2003-05-14
AU8220101A (en) 2002-02-25
AU2001282201B2 (en) 2006-05-11
HUP0300732A3 (en) 2005-09-28
TWI282275B (en) 2007-06-11
WO2002014464A3 (fr) 2002-05-10
KR100851357B1 (ko) 2008-08-08
HUP0300732A2 (hu) 2003-09-29
ATE441424T1 (de) 2009-09-15
WO2002014464A2 (fr) 2002-02-21
NO20030728D0 (no) 2003-02-14
NZ524128A (en) 2006-01-27
KR20030051623A (ko) 2003-06-25
BR0113463A (pt) 2003-07-15
AR034141A1 (es) 2004-02-04
MXPA03001435A (es) 2004-12-13
PT1309333E (pt) 2009-09-29
EP1309333B1 (fr) 2009-09-02
DE60139783D1 (de) 2009-10-15
CZ2003449A3 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
HUP0300732A3 (en) Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections
PL362405A1 (en) Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections
MXPA03005275A (es) Prevencion de la captacion de conservantes en biomateriales.
EG22394A (en) Acidic antimicrobial compositions for treating food and food contact surfaces and methods of use thereof
MXPA03005731A (es) Articulo absorbente que tiene tratamientos medicinales liberables.
MXPA03002945A (es) Articulos absorbentes que mejoran la funcion de barrera de la piel.
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
HRP20020042A2 (en) Method of increasing the content of flavonoids and phenolic substances in plants
AU2002247876A1 (en) Herbal composition for treatment of neuronal injuries and neuronal degeneration, methods to prepare the same and uses thereof
SG104943A1 (en) Absorbent article and barrier agent for absorbent article
GB0001734D0 (en) Chitosan condensation products their preparation and their uses
GB0009344D0 (en) Fabric treatment article and composition
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
PL361836A1 (en) Prevention of hoof infections in stockbreeding
AU2001275778A1 (en) Lemon extract and treatment methods
IL161091A0 (en) Compositions for the treatment and prevention of plant pathogens
ZA200210123B (en) Preparation with vascular protective and anti-oxidative effect and use thereof.
MXPA03002887A (es) Metodo y composicion para el tratamiento de sistemas de recoleccion de aguas negras.
EP1305017A4 (fr) Procedes et compositions pour la prevention et le traitement du syndrome x
AR027958A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades vasculares, que comprende propionil l-carnitina y coenzima q10
DE50103111D1 (de) Flaschenbehandlungsanlage
EP1264600A4 (fr) Composition de renforcement immunitaire et utilisation de ces compositions
HUP0300083A3 (en) Composition for the prevention and/or treatment of the cytotoxic effects induced by the use of immunosuppressive agents
ZA200304519B (en) Absorbent article having releasable medicinal treatments.